This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
I’m a doctor and epidemiologist, so you might expect me to be religious about preventative care: yearly visits to my primary care physician, that sort of thing. But I know we can’t prevent most disease and a lot of what we do in medicine doesn’t add value and sometimes even causes harm. So instead, I practice a seemingly radical but necessary idea for getting the best from medicine while avoiding excesses.
The use of artificial intelligence in hospitals is ramping up so fast — and with such little transparency — that it is impossible to track how any given product is impacting the cost or quality of care. Whether AI is monitored at all is entirely up to individual health systems. “Everybody is doing this differently, and many health systems are not doing it,” said Mike Pencina, chief data scientist at Duke Health.
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
High-profile gene editing startup Tome Biosciences said in a legal filing Friday that it will terminate virtually its entire staff beginning Nov. 1. The Massachusetts WARN notice comes a day after STAT reported the company was in dire straits, with one source saying that it planned to wind down operations and seek a buyer by Nov. 1 after the company struggled to raise money or find a partner.
High and medium-level supply notifications have been issued for norethisterone, methylphenidate prolonged-release and some naltrexone medications. 'High impact' ADHD med shortage may require paper prescriptions Yesterday (22 August) the Department of Health and Social Care (DHSC) issued a 'high impact' medicine supply notification for methylphenidate prolonged-release tablets.
117
117
Signup to get articles personalized to your interests!
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
High and medium-level supply notifications have been issued for norethisterone, methylphenidate prolonged-release and some naltrexone medications. 'High impact' ADHD med shortage may require paper prescriptions Yesterday (22 August) the Department of Health and Social Care (DHSC) issued a 'high impact' medicine supply notification for methylphenidate prolonged-release tablets.
Several years ago, while on a road trip, I ordered the now-discontinued spaghetti and meatballs during a pitstop at Denny’s. When the plate came out, I thought there was no way I could finish the massive platter, but then I did because it was right in front of me — even though I knew exactly what was going on. As an assistant professor of health policy, I examine the food environment and how we can encourage healthier choices.
Pharmacy leaders have urged the government to engage with pharmacy teams, as it appears to be reviewing its work to tackle major conditions. Earlier this month, public health minister Andrew Gwynne confirmed that work the government's major conditions strategy had been paused, saying: 'As we develop our plans to rebuild the NHS, we will consider […] The post Engage with pharmacy teams on major conditions, leaders urge government appeared first on The Pharmacist.
A diagnostics company has agreed to stop selling two questionable blood tests as part of a settlement with a consumer watchdog that accused the firm of using “false and misleading advertising” to promote the products. Not only was EpicGenetics claiming that one of its blood tests could definitively diagnose fibromyalgia, the Center for Science in the Public Interest’s October 2023 lawsuit said; the company had also invented a disease wholesale to justify the use of ano
Discover how patient organizations play a key role in enabling drug development with the support of EFPIA. Learn more about their involvement and impact in the pharmaceutical industry.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
A U.S. government agency said that a planned move by Johnson & Johnson to alter payment methods for some hospitals participating in a controversial drug discount program was “inconsistent” with federal law and requires approval before the company can proceed. The statement by the U.S. Health Resources and Services Administration came in response to a J&J plan to issue rebates for two widely prescribed medicines instead of offering discounted prices.
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still on the drawing board, but we do plan to catch up on our reading and napping, promenade with the official mascots, and hold another listening party with Mrs. Pharmalot, and the rotation will likely include this , this , this , this and this.
Dr Reddy’s Laboratories has set a new Guinness World Record for building the largest brochure mosaic (logo) installation. This installation is part of its glycemic happiness awareness initiative for patients with Type 2 diabetes mellitus. The largest installation that entered the Guinness World Record stands at 162 square metres and consists of feedback from healthcare professionals across India on the ‘Glycemic Happiness Scale’.
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.
Lupin announced that it has received approval from Health Canada for its biosimilar Pegfilgrastim. This product will be marketed under the brand name Armlupeg and manufactured at Lupin’s Biotech facility in Pune, India. Pegfilgrastim is a Pegylated form of the recombinant human granulocyte colony-stimulating factor (G-CSF) analogue Filgrastim. Pegfilgrastim prefilled syringes are indicated to decrease the incidence of infection, as manifested by febrile neutropenia in patients with non-myeloid m
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Sun Pharma has launched Tedizolid Phosphate tablets 200 mg in India under the brand name “STARIZO”. STARIZO (Tedizolid Phosphate) is a novel, oxazolidinone-class antibacterial, used to treat Acute Bacterial Skin and Skin Structure Infection (ABSSSI). Sun Pharma has obtained rights from MSD to develop, manufacture and commercialise Tedizolid Phosphate in India.
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
The FDA has approved new versions of Pfizer/BioNTech's Comirnaty and Moderna's Spikevax COVID-19 vaccines that target the Omicron KP.2 strain of SARS-CoV-2 which was dominant in the US in recent months.Both new mRNA-based vaccines have been approved for use in people aged 12 and over – and been granted emergency use authorisation for younger people aged 6 months to 11 years – and will be available within the next few days, said the drugmakers.
The Ministry of Health and Family Welfare has banned 156 fixed-dose combinations (FDCs) medicines which include commonly used antibiotics, antiallergy medication, painkillers and multivitamins. The decision comes following an expert group appointed by the central government and recommendations by the Drug Technical Advisory Board (DTAB). The gazette notification stated, “The said Expert Committee considered this FDC as irrational.
Learn about the fascinating world of artificial intelligence (AI) and machine learning in this informative article. Explore the concepts, applications, and impact of AI in various industries.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content